Financhill
Back

Mirati Therapeutics Stock Price Chart

  • The current trend is relatively stagnant and MRTX is experiencing selling pressure, which indicates risk of future bearish movement.

Mirati Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 48.89 Buy
20-day SMA: 45.93 Buy
50-day SMA: 55.97 Sell
200-day SMA: 64.68 Sell
8-day EMA: 49.46 Buy
20-day EMA: 47.82 Buy
50-day EMA: 52.73 Sell
200-day EMA: 71.12 Sell

Mirati Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 56.93 Buy
Chaikin Money Flow: -517111 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.71 - 48.81) Buy
Bollinger Bands (100): (47.08 - 79.16) Sell

Mirati Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Mirati Therapeutics Stock

Is Mirati Therapeutics Stock a Buy?

MRTX Technical Analysis vs Fundamental Analysis

Buy
51
Mirati Therapeutics (MRTX) is a Buy

Is Mirati Therapeutics a Buy or a Sell?

Mirati Therapeutics Stock Info

Market Cap:
2.98B
Price in USD:
51.81
Share Volume:
985.96K

Mirati Therapeutics 52-Week Range

52-Week High:
124.81
52-Week Low:
32.96
Buy
51
Mirati Therapeutics (MRTX) is a Buy

Mirati Therapeutics Share Price Forecast

Is Mirati Therapeutics Stock a Buy?

  • Mirati Therapeutics share price is 51.81 while MRTX 8-day exponential moving average is 49.46, which is a Buy signal.
  • The stock price of MRTX is 51.81 while Mirati Therapeutics 20-day EMA is 47.82, which makes it a Buy.
  • Mirati Therapeutics 50-day exponential moving average is 52.73 while MRTX share price is 51.81, making it a Sell technically.
  • MRTX stock price is 51.81 and Mirati Therapeutics 200-day simple moving average is 71.12, creating a Sell signal.

Fundamental Analysis of Mirati Therapeutics

Is Mirati Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $2.53 per share.

Technical Analysis of Mirati Therapeutics

Should I short Mirati Therapeutics stock?

* Mirati Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.